Dr. Tom Bergmans

Active

Private limited companyfounded 2022active for 4 yearsPerlamoenalaan 8, 2280 Grobbendonk, BelgiumKBO/BCE: BE 0790.461.908

Summary

The computed 12-month bankruptcy probability of Dr. Tom Bergmans is 1.9% (moderate). The 2024 annual accounts show equity of €166,097 and a net result of €97,598. Equity is growing by about 112% per year across the filed financial years. The company has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals.

Risk analysisFollow Report Compare

Dr. Tom BergmansActiveChecked score 57/100

Risk analysis Report Compare

History

On 5 September 2022, Dr. Tom Bergmans was incorporated as a private limited company.¹ In 2023 the registered office moved to Grobbendonk.² Total assets went from €19,763 in 2022 to €218,570 in 2024.³

Acts, filings and financial milestones

All 6Financial 2Gazette 1Filings 3

2025

31-10

NBB filing Annual accounts filed

financial year 2024 · micro format · 92 days late

2024

31-12

Financial Highest result from 2022 to 2024net €97,598 ▲74.9%

Operating result €127,688, net result €97,598, both a record.

31-12

Financial Equity above €150,000equity €166,097 ▲142%

A profit in every financial year since 2022 builds equity to €166,097.

27-11

NBB filing Annual accounts filed

financial year 2023 · micro format · 119 days late

2023

27-10

NBB filing Annual accounts filed

financial year 2022 · micro format · 88 days late

18-09

Gazette deed Permanent representative: Iris Carsau

Registered-office move3 facts ▸

General meeting, 15-08-2023
Registered-office move, Perlamoenalaan 8, 2280 Grobbendonk
Permanent representative, Iris Carsau

Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.

1 of 2 deeds read

About the unread acts

Of the 2 Belgian Official Gazette deeds we know for this company, 1 has been read. The other one has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.